Nivolumab
Nivolumab
Latest Posts
-
Neoadjuvant immunotherapy using nivolumab prior to early lung cancer surgery is safe and feasible
Adapted from Press release by European Society for Medical OncologyNeoadjuvant immunotherapy with the PD-1 inhibitor nivolumab is safe and feasible prior to surgery for early lung cancer, researchers reported at the ESMO 2016 Congress in Copenhagen. Background…
You must be logged in to post a comment.